B7 - Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)
Autor: | Paganelli, G., Procopio, G., Cabria, M., Cortesi, E., Tucci, M., Farnesi, A., Mango, L., Baldari, S., Hamzaj, A., Caffo, O., Marchetti, P., Dalla Pozza, F., Zucali, P., Barsanti, R., Saad, F. |
---|---|
Zdroj: | In Annals of Oncology October 2017 28 Supplement 6:vi18-vi19 |
Databáze: | ScienceDirect |
Externí odkaz: |